Eva Esteban‐Cardeñosa

Author

Instituto de Biomedicina y Genética Molecular de Valladolid

Also Known As

E Esteban‐Cardeñosa, E. Esteban-Cardenosa, Eva Esteban-Cardeñosa, Eva Esteban-Cardeñosa, Eva Esteban‐Cardeñosa, Eva M. Esteban-Cardeñosa, Eva M. Esteban‐Cardeñosa

Publications

467

Citations

H-Index

Concepts

All Affiliations

Instituto de Biomedicina y Genética Molecular de Valladolid Universidad de Valladolid Spanish National Cancer Research Centre Hospital de Sant Pau Consejo Superior de Investigaciones Científicas

About

Eva Esteban‐Cardeñosa is an author at Instituto de Biomedicina y Genética Molecular de Valladolid specializing in medicine, genetics, and breast cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	186
2	Molecular Genetics	5	5	139
3	Engineering	2	2	42
4	Public Health	2	2	40
5	Molecular Biology	2	2	73

Eva Esteban‐Cardeñosa

Publications

449

Citations

H-Index

Page 1

	Year	Citations
A High Proportion of DNA Variants of <i>BRCA1</i> and <i>BRCA2</i> Is Associated with Aberrant Splicing in Breast/Ovarian Cancer Patients David J. Sanz, Alberto Acedo, Mar Infante, Clinical Cancer Research	2010	108
The breast cancer low‐penetrance allele 1100delC in the CHEK2 gene is not present in Spanish familial breast cancer population Ana Osório, Raquel Rodríguez‐López, Miguel de la Hoya, International Journal of Cancer	2003	81
Heteroduplex analysis by capillary array electrophoresis for rapid mutation detection in large multiexon genes Eladio A. Velasco, Mar Infante, M. Durán, Nature Protocols Genetic AnalysisDna SequencingRapid Mutation DetectionMedicineGenetics	2007	47
High proportion of novel mutations of BRCA1 and BRCA2 in breast/ovarian cancer patients from Castilla-León (central Spain) Mar Infante, M. Durán, Eva Esteban‐Cardeñosa, Journal of Human Genetics High ProportionBreast/ovarian Cancer PatientsSomatic VariantBreast OncologyMedicine	2006	37
About 1% of the breast and ovarian Spanish families testing negative for <i>BRCA1</i> and <i>BRCA2</i> are carriers of <i>RAD51D</i> pathogenic variants Sara Gutiérrez‐Enríquez, Sandra Bonache, Gorka Ruíz de Garibay, International Journal of Cancer Genetic TestingGeneticsGenetic EpidemiologyPathologyMolecular Genetics	2013	30
High-Throughput Mutation Detection Method to Scan BRCA1 and BRCA2 Based on Heteroduplex Analysis by Capillary Array Electrophoresis Eva Esteban‐Cardeñosa, M. Durán, Mar Infante, Clinical Chemistry	2004	29
The variant E233G of the <i>RAD51D</i> gene could be a low‐penetrance allele in high‐risk breast cancer families without <i>BRCA1/2</i> mutations Raquel Rodríguez‐López, Ana Osório, Gloría Ribas, International Journal of Cancer	2004	27
Rapid mutation detection in complex genes by heteroduplex analysis with capillary array electrophoresis Eladio A. Velasco, Mar Infante, M. Durán, Electrophoresis EngineeringGeneticsDna AnalysisMolecular BiologyMolecular Genetics	2005	26
Mutational analysis of<i>BRCA2</i>in Spanish breast cancer patients from Castilla-Leon: Identification of four novel truncating mutations M. Durán, Eva Esteban‐Cardeñosa, Eladio A. Velasco, Human Mutation Breast OncologyMutational AnalysisCancer PathologySomatic VariantMedicine	2003	20
The highly prevalent BRCA2 mutation c.2808_2811del (3036delACAA) is located in a mutational hotspot and has multiple origins Mar Infante, M. Durán, Alberto Acedo, Carcinogenesis	2013	18

Page 1